27/06/2022
07:15:10
+44 (0) 203 8794 460
Free Membership
Login
Watchlist
Kurse
Charts
Trades
News
Fundamental
Toplisten
Alerts
Portfolio
Orderbuch
Forum
PLUS1
Krypto
Börse & Märkte
Devisen
Rohstoffe
Welt Märkte
Follow Feed
Treten Sie unserer Gemeinschaft von Investoren!
JETZT ANMELDEN
Startseite
Investieren
Aktien
Kanada
TSX
Acerus Pharmaceuticals Corporation
(ASP)
Finanzwerte
Börsenkurse
Charts
Orderbuch
Trades
News
Finanzwerte
Historisch
Acerus Pharmaceuticals Corporation (ASP) Fundamentals
Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.
SHARE INFORMATION
Market Cap
$ 17.341.313
Shares Outstanding
7.707.747
Float
-
Percent Float
0,0%
Short Interest
259,00
Short Percent Float
100,0%
Short Interest Ratio
0,318966
Short Interest Date
2022-06-15
Latest Fiscal Dividend Per Share
$ 0,00
Latest Fiscal Revenue
$ -5.223.760
Latest Fiscal EPS
$ -5,06
Latest Fiscal Date
2021-12-31
DIVIDENDS
Dividend (3 Years)
$ 0,00
Dividend (5 Years)
$ 0,00
Ex Dividend Date
-
Dividend Rate
$ 0,00
Dividend Yield
0,0%
Payment Cash
-
HOLDERS
Institutions
1
Institutional Holdings Date
2020-04-30
Institutional Bought Previous 3 Months
-
Institutional Holdings Percent
0,0%
Institutional Sold Previous 3 Months
-
Insider Holdings Date
-
Insider Bought Previous 3 Months
-
Insider Holdings Percent
0,0
Insider Sold Previous 3 Months
-
Insider Shares Owned
1.435.197.562
TRADING INFO
52 Week High
$ 11,00
52 Week Low
$ 2,25
52 Week High Change
$ -75,00
21 Day Moving Average
$ 3,4024
21 Day Extended Moving Average
$ 3,4064
50 Day Moving Average
$ 4,6832
50 Day Extended Moving Average
$ 4,5645
200 Day Moving Average
$ 6,8808
200 Day Extended Moving Average
$ 6,6963
10 Day Average Volume
185
20 Day Average Volume
525
30 Day Average Volume
483
50 Day Average Volume
1.497
Alpha
0.000273
Beta
1.088127
Standard Deviation
0.342568
R2
0.016732
7 Day Price Change
$ -0,85
7 Day Percent Change
-27,42%
21 Day Price Change
$ -1,95
21 Day Percent Change
-46,43%
30 Day Price Change
$ -1,70
30 Day Percent Change
-43,04%
Month to Date Price Change
$ -1,75
Month to Date Percent Change
-43,75%
Quarter to Date Price Change
$ -6,75
Quarter to Date Percent Change
-75,0%
180 Day Price Change
$ -2,75
180 Day Percent Change
-55,0%
200 Day Price Change
$ -2,75
200 Day Percent Change
-55,0%
Year to Date Price Change
$ -2,75
Year to Date Percent Change
-55,0%
Acerus Pharmaceuticals Corporation (ASP) Key Ratios
PROFITABILITY
EBIT Margin
-959,2%
EBITDA Margin
-940,9%
Pre-Tax Profit Margin
-858,1%
Profit Margin Count
0,0%
Gross Margin
55,9%
Profit Margin TOT
0,0%
INCOME STATEMENTS
Revenue
$ 3.311.646
Revenue Per Share
$ 0,429652
Revenue (3 Years)
$ 0,00
Revenue (5 Years)
$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book
-0,34
Total Debt To Equity
2,61
Int Coverage
-8,90
Current Ratio
0,50
Leverage Ratio
-1,20
Quick Ratio
0,20
Long Term Debt To Capital
0,68
VALUATION MEASURES
PE Ratio
-0,70
Enterprise Value
$ 58.605.425
Price to Sales
5,2368
Price to Free Cash
-0,50
PE High Last 5 Years
7,70
Price To Book
18,06
Price To Cash Flow
595,00
PE Low Last 5 Years
-2,20
Price to Tangible Book
-0,34
MANAGEMENT EFFECTIVENESS
Receivables Turnover
1,20
Invoice Turnover
0,30
Assets Turnover
0,00
Return Assets
-92,67
Return on Equity
399,59
Return on Capital
-316,75
Acerus Pharmaceuticals Corporation (ASP) Profile
PROFILE INFO
Issue Type
CS
SEC Type
EQS
Auditor
PricewaterhouseCoopers LLP
CEO
Edward Gudaitis
Emplyoees
14
Last Audit
UE
CIK
0001527246
Industry
Drug Manufacturers
Sector
Healthcare
NAICS
Pharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address
7025 Langer Drive
Suite 205
Mississauga, ON L5N 0E8
Website
https://www.aceruspharma.com
Facsimile
+1 905 569-1809
Telephone
+1 289 326-5789
Email
IR@aceruspharma.com
Kürzlich von Ihnen besucht
TSX
ASP
Acerus Pha..
Register now
to watch these stocks streaming on the ADVFN Monitor.
Monitor lets you view up to 110 of your favourite stocks at once and is
completely free
to use.
Der Markt LS (Lang&Schwarz) wird als Realtime Indikation kostenlos angezeigt und bietet Ihnen außerbörsliche Realtime Aktienkurse in der Zeit von Mo-Fr 08:00 bis 23:00, Samstags 10:00 bis 13:00 und Sonntags an.
NYSE und AMEX Kurse sind um mindestens 20 Minuten zeitverzögert.
Alle weiteren Kurse sind um mindestens 15 Minuten zeitverzögert, sofern nicht anders angegeben.
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende
Allgemeine Geschäftsbedingungen
Investitionen Warnung
Copyright © 1999 - 2022
Datenschutzrichtlinie
Zustimmungseinstellungen
ADVFN UK
Investors Hub
ADVFN Italy
ADVFN Australia
ADVFN Brazil
ADVFN Canada
ADVFN Germany
ADVFN Japan
ADVFN Mexico
ADVFN France
ADVFN US
P: V:de D:20220627 06:15:10
Login
Ihre Daten wurden nicht erkannt.
Bitte versuchen Sie es nochmal
Benutzername
Passwort
Passwort vergessen?
support@advfn.de
Haben Sie kein Konto?
Jetzt registrieren